467 related articles for article (PubMed ID: 25970242)
1. MYC regulates the core pre-mRNA splicing machinery as an essential step in lymphomagenesis.
Koh CM; Bezzi M; Low DH; Ang WX; Teo SX; Gay FP; Al-Haddawi M; Tan SY; Osato M; Sabò A; Amati B; Wee KB; Guccione E
Nature; 2015 Jul; 523(7558):96-100. PubMed ID: 25970242
[TBL] [Abstract][Full Text] [Related]
2. Regulation of constitutive and alternative splicing by PRMT5 reveals a role for Mdm4 pre-mRNA in sensing defects in the spliceosomal machinery.
Bezzi M; Teo SX; Muller J; Mok WC; Sahu SK; Vardy LA; Bonday ZQ; Guccione E
Genes Dev; 2013 Sep; 27(17):1903-16. PubMed ID: 24013503
[TBL] [Abstract][Full Text] [Related]
3. PRMT5 regulates IRES-dependent translation via methylation of hnRNP A1.
Gao G; Dhar S; Bedford MT
Nucleic Acids Res; 2017 May; 45(8):4359-4369. PubMed ID: 28115626
[TBL] [Abstract][Full Text] [Related]
4. Identification of MYC intron 2 regions that modulate expression.
Tompkins VS; Xue Z; Peterson JM; Rouse WB; O'Leary CA; Moss WN
PLoS One; 2024; 19(1):e0296889. PubMed ID: 38236931
[TBL] [Abstract][Full Text] [Related]
5. A novel intron element operates posttranscriptionally To regulate human N-myc expression.
Sivak LE; Pont-Kingdon G; Le K; Mayr G; Tai KF; Stevens BT; Carroll WL
Mol Cell Biol; 1999 Jan; 19(1):155-63. PubMed ID: 9858540
[TBL] [Abstract][Full Text] [Related]
6. Coordinated Splicing of Regulatory Detained Introns within Oncogenic Transcripts Creates an Exploitable Vulnerability in Malignant Glioma.
Braun CJ; Stanciu M; Boutz PL; Patterson JC; Calligaris D; Higuchi F; Neupane R; Fenoglio S; Cahill DP; Wakimoto H; Agar NYR; Yaffe MB; Sharp PA; Hemann MT; Lees JA
Cancer Cell; 2017 Oct; 32(4):411-426.e11. PubMed ID: 28966034
[TBL] [Abstract][Full Text] [Related]
7. Loss-of-function mutation in PRMT9 causes abnormal synapse development by dysregulation of RNA alternative splicing.
Shen L; Ma X; Wang Y; Wang Z; Zhang Y; Pham HQH; Tao X; Cui Y; Wei J; Lin D; Abeywanada T; Hardikar S; Halabelian L; Smith N; Chen T; Barsyte-Lovejoy D; Qiu S; Xing Y; Yang Y
Nat Commun; 2024 Apr; 15(1):2809. PubMed ID: 38561334
[TBL] [Abstract][Full Text] [Related]
8. Cellular redox homeostasis maintained by malic enzyme 2 is essential for MYC-driven T cell lymphomagenesis.
Li W; Kou J; Zhang Z; Li H; Li L; Du W
Proc Natl Acad Sci U S A; 2023 Jun; 120(23):e2217869120. PubMed ID: 37253016
[TBL] [Abstract][Full Text] [Related]
9. Exploiting the Hidden Treasure of Detained Introns.
Fu XD
Cancer Cell; 2017 Oct; 32(4):393-395. PubMed ID: 29017049
[TBL] [Abstract][Full Text] [Related]
10. Caspase-resistant ROCK1 expression prolongs survival of Eµ-Myc B cell lymphoma mice.
Mardilovich K; Naylor G; Julian L; Phinichkusolchit N; Keeshan K; Blyth K; Olson MF
Dis Model Mech; 2024 Apr; ():. PubMed ID: 38616733
[TBL] [Abstract][Full Text] [Related]
11. The spliceosome is a therapeutic vulnerability in MYC-driven cancer.
Hsu TY; Simon LM; Neill NJ; Marcotte R; Sayad A; Bland CS; Echeverria GV; Sun T; Kurley SJ; Tyagi S; Karlin KL; Dominguez-Vidaña R; Hartman JD; Renwick A; Scorsone K; Bernardi RJ; Skinner SO; Jain A; Orellana M; Lagisetti C; Golding I; Jung SY; Neilson JR; Zhang XH; Cooper TA; Webb TR; Neel BG; Shaw CA; Westbrook TF
Nature; 2015 Sep; 525(7569):384-8. PubMed ID: 26331541
[TBL] [Abstract][Full Text] [Related]
12. RNA splicing: MYC maintains high-fidelity splicing.
Seton-Rogers S
Nat Rev Cancer; 2015 Jul; 15(7):385. PubMed ID: 26084393
[No Abstract] [Full Text] [Related]
13. Disordered methionine metabolism in MTAP/CDKN2A-deleted cancers leads to dependence on PRMT5.
Mavrakis KJ; McDonald ER; Schlabach MR; Billy E; Hoffman GR; deWeck A; Ruddy DA; Venkatesan K; Yu J; McAllister G; Stump M; deBeaumont R; Ho S; Yue Y; Liu Y; Yan-Neale Y; Yang G; Lin F; Yin H; Gao H; Kipp DR; Zhao S; McNamara JT; Sprague ER; Zheng B; Lin Y; Cho YS; Gu J; Crawford K; Ciccone D; Vitari AC; Lai A; Capka V; Hurov K; Porter JA; Tallarico J; Mickanin C; Lees E; Pagliarini R; Keen N; Schmelzle T; Hofmann F; Stegmeier F; Sellers WR
Science; 2016 Mar; 351(6278):1208-13. PubMed ID: 26912361
[TBL] [Abstract][Full Text] [Related]
14. Prmt5 is a regulator of muscle stem cell expansion in adult mice.
Zhang T; Günther S; Looso M; Künne C; Krüger M; Kim J; Zhou Y; Braun T
Nat Commun; 2015 Jun; 6():7140. PubMed ID: 26028225
[TBL] [Abstract][Full Text] [Related]
15. MTAP deletion confers enhanced dependency on the PRMT5 arginine methyltransferase in cancer cells.
Kryukov GV; Wilson FH; Ruth JR; Paulk J; Tsherniak A; Marlow SE; Vazquez F; Weir BA; Fitzgerald ME; Tanaka M; Bielski CM; Scott JM; Dennis C; Cowley GS; Boehm JS; Root DE; Golub TR; Clish CB; Bradner JE; Hahn WC; Garraway LA
Science; 2016 Mar; 351(6278):1214-8. PubMed ID: 26912360
[TBL] [Abstract][Full Text] [Related]
16. The dual epigenetic role of PRMT5 in acute myeloid leukemia: gene activation and repression via histone arginine methylation.
Tarighat SS; Santhanam R; Frankhouser D; Radomska HS; Lai H; Anghelina M; Wang H; Huang X; Alinari L; Walker A; Caligiuri MA; Croce CM; Li L; Garzon R; Li C; Baiocchi RA; Marcucci G
Leukemia; 2016 Apr; 30(4):789-99. PubMed ID: 26536822
[TBL] [Abstract][Full Text] [Related]
17. Antisense oligonucleotide-mediated MDM4 exon 6 skipping impairs tumor growth.
Dewaele M; Tabaglio T; Willekens K; Bezzi M; Teo SX; Low DH; Koh CM; Rambow F; Fiers M; Rogiers A; Radaelli E; Al-Haddawi M; Tan SY; Hermans E; Amant F; Yan H; Lakshmanan M; Koumar RC; Lim ST; Derheimer FA; Campbell RM; Bonday Z; Tergaonkar V; Shackleton M; Blattner C; Marine JC; Guccione E
J Clin Invest; 2016 Jan; 126(1):68-84. PubMed ID: 26595814
[TBL] [Abstract][Full Text] [Related]
18. Myc and Omomyc functionally associate with the Protein Arginine Methyltransferase 5 (PRMT5) in glioblastoma cells.
Mongiardi MP; Savino M; Bartoli L; Beji S; Nanni S; Scagnoli F; Falchetti ML; Favia A; Farsetti A; Levi A; Nasi S; Illi B
Sci Rep; 2015 Nov; 5():15494. PubMed ID: 26563484
[TBL] [Abstract][Full Text] [Related]
19. Recursive splicing in long vertebrate genes.
Sibley CR; Emmett W; Blazquez L; Faro A; Haberman N; Briese M; Trabzuni D; Ryten M; Weale ME; Hardy J; Modic M; Curk T; Wilson SW; Plagnol V; Ule J
Nature; 2015 May; 521(7552):371-375. PubMed ID: 25970246
[TBL] [Abstract][Full Text] [Related]
20. Targeting methyltransferase PRMT5 eliminates leukemia stem cells in chronic myelogenous leukemia.
Jin Y; Zhou J; Xu F; Jin B; Cui L; Wang Y; Du X; Li J; Li P; Ren R; Pan J
J Clin Invest; 2016 Oct; 126(10):3961-3980. PubMed ID: 27643437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
